12 Patents
- 0 cites
- US123981532025Spiro Compound Serving as ERK Inhibitor, and Application Thereof
D3 BIO (WUXI) CO., Ltd.
0 cites - US123782772025SGLTS/DPP4 Inhibitor and Application Thereof
DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., Ltd.
0 cites - US123446202025BRD4 Inhibitor Compound in Solid Form and Preparation Method Therefor and Use Thereof
CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., Ltd.
0 cites - US122583672025Glucoside Derivative That Acts as SGLT1 Inhibitor and Application Thereof
MEDSHINE DISCOVERY Inc.
0 cites - US120180272024Macrocyclic Derivatives Acting as Xia Factor Inhibitor
China Resources Biopharmaceutical Company Limited
0 cites - US118664332024Diarylthiohydantoin Compound as Androgen Receptor Antagonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., Ltd.
0 cites - 0 cites
- US118143822023Crystal Form as ASK1 Inhibitor and Preparation Method and Application Thereof
FUJIAN AKEYLINK BIOTECHNOLOGY CO., Ltd.
0 cites - 0 cites
- US117390902023Substituted Pyrazlo[3,4-c]pyridines as Selective BTK Kinase Inhibitors
JUMBO DRUG BANK CO., Ltd.
0 cites - US115422722023Five-membered Heteroaryl-fused Imidazole Compound and Application Thereof
Hangzhou Sciwind Biosciences Co., Ltd
0 cites